European Town Hall: Part 1 of 2 - Hot Topics in Europe
Monday, June 25, 2012
10:00-11:30 AM ET

The European medicines system offers different ways of bringing new medicines to the patient, such as through the European Medicines Agency centralized route or through the European national agencies’ decentralized route. This first part of the European Town Hall offers the opportunity to hear from EMA and national agencies’ senior leaders on a number of important topics in European regulatory network. A second part offers insights on practical interactions with the European system.

Submit questions in advance to



Guido Rasi, MDGuido Rasi, MD
Executive Director
European Medicines Agency
European Union


Hans-Georg Eichler, MD,MScHans-Georg Eichler, MD,MSc
Senior Medical Officer
European Medicines Agency
European Union
Aginus A. W. Kalis, MDAginus A. W. Kalis, MD
Executive Director
Medicines Evaluation Board
The Netherlands

European Town Hall: Part 2 of 2 - Interacting With the European System
Monday, June 25, 2012
1:30 - 3:00 PM ET

Part 2 of the European Town Hall offers a new vision on the different initiatives and entry points to facilitate regulatory procedures and scientific dialogue from early development to post-marketing authorization stages. The forum offers the chance to interact directly with representatives from the European Medicines Agency and European national agencies.


Christa Wirthumer-Hoche, PhDChrista Wirthumer-Hoche, PhD
Deputy Head of AGES PharmMed
AGES PharmMed


Xavier De CuyperXavier De Cuyper
Chief Executive Officer
Federal Agency for Medicines and Health Products (FAMHP)
Peter Bachmann, DrScPeter Bachmann, DrSc
Senior Expert; Chair
Coordination Group for Mutual Recognition and Decentralise BfArM Germany
Agnès Saint-Raymond, MDAgnès Saint-Raymond, MD
Head, Human Medicines, Special Areas,  European Medicines Agency